Petra J. Ter Brugge
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Journal: Nature communications
Published: April 14, 2022
Author Correction: Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Journal: Nature genetics
Published: February 20, 2021
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Journal: Science translational medicine
Published: March 12, 2019
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data.
Journal: BMC bioinformatics
Published: February 16, 2018
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.
Journal: Journal of the National Cancer Institute
Published: December 02, 2015
The use of mass spectrometry imaging to predict treatment response of patient-derived xenograft models of triple-negative breast cancer.
Journal: Journal of proteome research
Published: January 03, 2015
Functional ex vivo assay to select homologous recombination-deficient breast tumors for PARP inhibitor treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 26, 2014
Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.
Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.
Journal: Nature biotechnology
Published: November 26, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026